Significance of chemokines and activated platelets in patients with diabetes

Citation
S. Nomura et al., Significance of chemokines and activated platelets in patients with diabetes, CLIN EXP IM, 121(3), 2000, pp. 437-443
Citations number
47
Categorie Soggetti
Immunology
Journal title
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
ISSN journal
00099104 → ACNP
Volume
121
Issue
3
Year of publication
2000
Pages
437 - 443
Database
ISI
SICI code
0009-9104(200009)121:3<437:SOCAAP>2.0.ZU;2-K
Abstract
Levels of platelet-derived microparticles (PMPs), platelet activation marke rs (P-selectin expressed on, or annexin V binding to, platelets (plt:P-sele ctin or plt:annexin V, respectively)), chemokines (IL-8, monocyte chemotact ic peptide-1 (MCP-1), and regulated on activation normally T-cell expressed and secreted (RANTES)), and soluble P- and E-selectins were compared in pe ripheral blood from diabetic and control patients in order to develop a bet ter understanding of their potential contribution to diabetic vascular comp lications. Significant increases were found for PMPs, plt:P-selectin, MCP-1 , RANTES and soluble P- and E-selectins in diabetic individuals, whereas IL -8 levels were similar. Furthermore, after ticlopidine treatment, most of t hese factors receded to baseline levels observed in non-diabetic patients. Our findings indicate that ticlopidine might be able to prevent or reduce v ascular complications in diabetic patients.